73 indexable Life Sciences companies headquartered in Utrecht, Netherlands, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $459.7M across 30 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vitestro
Developed AI-based blood drawing robot for clinic use |
$50M | — | Series B | Series B Mar 2026 | 50 | 2017 | ↑ Active |
| 2 |
Kaleido
Developer of insulin therapy for treating diabetes |
$85.3M | — | Series D | Series D Jan 2026 | 129 | 2013 | ↑ Active |
| 3 |
TargED
Developer of biological drugs for the treatment of thrombosis |
$45.8M | — | Series A | Series A Dec 2025 | 17 | 2020 | ↑ Active |
| 4 |
Scinus
Developer of closed-system bioreactors for cell therapy production |
$3.5M | — | Series A | Series A Mar 2026 | 8 | 2016 | ↑ Active |
| 5 |
AMT Medical
Providing solutions for heart bypass surgery |
$11.7M | — | Series B | Series B Apr 2025 | 21 | 2016 | ↑ Active |
| 6 |
Guideways
AI agents automate medtech approval and maintenance processes for faster market access. |
$1.2M | — | Seed | Seed Nov 2025 | — | 2024 | ↑ Active |
| 7 |
CryoCloud
Provider of cloud-based platform for Cryo-EM data analysis |
$541.4K | — | Seed | Seed May 2025 | — | 2021 | ↑ Active |
| 8 |
Bilthoven Biologicals
Large scale vaccines manufacturer for infectious diseases, such as polio and tetanus |
$28.6M | — | Acquired | Grant (prize money) Jun 2023 | 371 | 2012 | — |
| 9 |
Merus
Developer of antibody-based drugs for cancer treatment |
$156.2M | — | Acquired | Post IPO Dec 2018 | 221 | 2003 | — |
| 10 |
SentryX
Developer of therapeutics for pain treatment after surgery |
$16.7M | — | Funding Raised | Grant (prize money) Apr 2023 | 20 | 2017 | — |
| 11 |
Xpand Biotechnology
Developer of alternative bio-reactors for 2D cell culture |
$17.1M | — | Acquired | Grant (prize money) Jun 2017 | 15 | 2004 | — |
| 12 |
Prolira
Developer of a non-invasive device for the early detection of delirium |
$5.7M | — | Series B | Series B Feb 2022 | 12 | 2015 | — |
| 13 |
Gadeta
T Cell based cancer therapies based on gamma delta (γδ) T cell receptors |
$7.8M | — | Acquired | Grant (prize money) Dec 2020 | 31 | 2015 | — |
| 14 |
Cleara
Developer of biomarkers and therapies to treat cancer and aging diseases |
$2.5M | — | Seed | Seed Sep 2022 | 10 | 2017 | — |
| 15 |
MRIguidance
Provider of MRI based bone diagnostic platform |
$3M | — | Seed | Seed Aug 2021 | 22 | 2016 | — |
| 16 |
Encare Biotech
Specialty company developing a new therapeutic antibody for the prevention of heart failure after acute myocardial infarction |
$6.8M | — | Deadpooled | PE Nov 2014 | — | 2014 | — |
| 17 |
Cergentis
Provider of kits and services for the targeted sequencing of genes |
$3M | — | Acquired | Grant (prize money) Apr 2020 | 39 | 2012 | — |
| 18 |
FF Pharma
MAbs for inflammatory diseases like primary biliary cirrhosis and Crohn’s disease |
$5.3M | — | Deadpooled | Series A Jan 2013 | — | 2012 | — |
| 19 |
MILabs
Develops Imaging Instruments for clinical and pre-clinical applications |
$2.7M | — | Acquired | Series A Oct 2016 | 48 | 2004 | — |
| 20 |
Apo-T
Dutch, private, biopharma company developing antibody-drug conjugates and apoptosis-inducers for cancer treatment |
$2.7M | — | Deadpooled | Grant (prize money) Apr 2014 | — | 2011 | — |
| 21 |
Core Life Analytics
Provider of a cloud-based data analytics solutions for life sciences |
$1.1M | — | Series A | Series A May 2020 | 10 | 2016 | — |
| 22 |
DC4U
Glycan based technology for immunotherapeutics |
$455.3K | — | Funding Raised | Grant (prize money) Apr 2020 | 2 | 2006 | — |
| 23 |
Cavadis
Developing medical prognostic tests for heart attack and stroke |
$686.5K | — | Series A | Grant (prize money) Feb 2010 | — | 2007 | — |
| 24 |
Hercules
Developer of Aryl Hydrocarbon Receptor inhibiting drug for Triple Negative Breast Cancer treatment |
$353.6K | — | Series A | Series A Aug 2020 | 2 | 2013 | — |
| 25 |
Triall
Provider of blockchain-based platform for clinical ecosystem |
$200K | — | Funding Raised | ICO Sep 2021 | 19 | 2018 | — |
| 26 |
FormsVision
Clinical development solutions and tools for clinical trials |
$165.4K | — | Deadpooled | Grant (prize money) Feb 2021 | — | 2009 | — |
| 27 |
MicroDish
Developer of microchips and reagents for microbial cell culture |
$282.3K | — | Seed | Grant (prize money) Nov 2016 | 4 | 2008 | — |
| 28 |
IDfuse
Provider of tool for writing grant proposals |
$121.2K | — | Funding Raised | Grant (prize money) Sep 2020 | — | 2012 | — |
| 29 |
Ascenscia
Provider of voice assistant to streamline lab work |
$28.4K | — | Seed | Seed Jan 2022 | 4 | 2020 | — |
| 30 |
Cyclomics
Developer of liquid biopsybased diagnostic test for cancer detection |
$56K | — | Funding Raised | Grant (prize money) Jun 2019 | — | 2018 | — |
| 31 |
GlycoTreat
Developer of glycan-mediated immunotherapies designed to treat and cure allergies |
— | — | Seed | Seed Aug 2025 | — | 2022 | ↑ Active |
| 32 |
Cresco
Developer of surgical spinal therapies for scoliosis |
— | — | Seed | Seed Jun 2022 | 4 | 2021 | — |
| 33 |
Innofuse
Developer of intensive care unit disposable IV set for neonatal |
— | — | Deadpooled | Jun 2020 | 3 | 2011 | — |
| 34 |
NTrans Technologies
Tool for cell manipulation |
— | — | Funding Raised | Aug 2019 | 8 | 2015 | — |
| 35 |
GenDx
Develops and markets a line of In Vitro Diagnostic (IVD) tests and services, analysis software and education |
— | — | Acquired | Series B May 2019 | 80 | 2005 | — |
| 36 |
Sapreme Technologies
Developer of macromolecular therapies to treat cancer |
— | — | Funding Raised | Grant (prize money) Feb 2019 | 19 | 2016 | — |
| 37 |
Photonics Healthcare
Provider of monitoring device for cellular oxygen levels |
— | — | Seed | Seed Oct 2013 | — | 2008 | — |
| 38 |
Abvion
Developer of therapeutic antibodies based on natural immune responses |
— | — | Unfunded | — | — | 2024 | — |
| 39 |
AQTIS Medical
Develops injectable medical devices for medical aesthetics |
— | — | Acqui-Hired | — | 54 | 2006 | — |
| 40 |
Ayuvant
Developer of RNA-nanoparticle immunotherapy designed to instruct the immune system. |
— | — | Funding Raised | — | — | 2024 | — |
| 41 |
brain science tools
Brain Science Tools BV is a UMC Utrecht/Utrecht University spinoff company based in Utrecht, The Netherlands. |
— | — | Private | — | 8 | 2011 | — |
| 42 |
Braincarta
Provider of software for analysis and clinical reporting of functional MRI scans |
— | — | Deadpooled | — | 2 | 2015 | — |
| 43 |
CART-Tech
Developer of cardiac regenerative therapy-based pacemaker |
— | — | Funding Raised | — | 8 | 2014 | — |
| 44 |
CrimsonBase
Tool for DNA analysis, assembly and cloning |
— | — | Deadpooled | — | — | 2009 | — |
| 45 |
Crossbeta
Using a propreitary oligomer-based tech platform to discover drugs against neurodegenerative diseases |
— | — | Deadpooled | — | 3 | 2005 | — |
| 46 |
Eaglet Eye
Developer of cornea measuring device |
— | — | Funding Raised | — | 10 | 2010 | — |
| 47 |
EdgeLeap
Data Science company |
— | — | Unfunded | — | — | 2014 | — |
| 48 |
elana
Elana specializes in developing and manufacturing medical devices for bypass surgery by maintaining a leading edge in bypass research. |
— | — | Acquired | — | 3 | 2004 | — |
| 49 |
Eqube
E-health platform to control over the right manual for medical devices |
— | — | Unfunded | — | — | 2014 | — |
| 50 |
Euretos
Developer of AI platform for in-silico discovery and validation of targets and biomarkers |
— | — | Unfunded | — | — | 2012 | — |
Developed AI-based blood drawing robot for clinic use. The company has developed a medical robotics device that autonomously draws blood from patients. The device has a guided 3D construction with a robotic needle that secures blood collection. It has features for bandage application as well.
Hello Kaleido develops an insulin pump for treating diabetes. It is a medical device used for the administration of insulin in the treatment of diabetes mellitus. It uses a Bluetooth channel to connect with the phone which reminds users of insulin administration. The company also provides software for diabetic monitoring.
Developer of biological drugs for the treatment of thrombosis. The company offers its FDA-approved biological drugs and TargED Targeted Enzyme Delivery system which is a small antibody that can target the specific sites of thrombosis and enable the blood flow to reduce the risk for organ failure is reduced. The company target Thrombotic thrombocytopenic purpura (TTP) and Acute Ischemic Stroke (AIS) and the lead compo
Developer of closed-system bioreactors for cell therapy production. It provides a cost-effective solution for cultivating clinically relevant cell numbers. The bioreactor system supports both research and development and Good Manufacturing Practice (GMP) processes. Utilizing single-use bags, it offers scalability for large-fold cell expansion. The system is adaptable for both adherent and suspension cell types, using
AMT MEDICAL is providing solutions for heart bypass surgery. Its AMT technology is based on total endoscopy coronary artery bypass surgery. With the use of a connector, laser catheter, and a small robot they make a small opening in the chest to perform surgery.
AI agents automate medtech approval and maintenance processes for faster market access. The company develops AI agents that streamline regulatory approval, post-market surveillance, quality management, and reimbursement processes for medical devices and software-as-medical devices. The AI analysis provides insights, and the platform facilitates connections with domain experts. The focus is on accelerating time to mar
Provider of cloud-based platform for Cryo-EM data analysis. It offers web-based application that provides researhers access to cloud resources, image analysis workflows and storage solutions for cryo-EM data analysis of protein structure.
Bilthoven Biologicals produces large scale vaccines for infectious diseases, such as polio and tetanus. It was acquired by Poonawalla Group (Serum Institute, Indian vaccine manufacturer) in Jul.2012. The company manufacturers more than 20M vaccine units each year and sells in more than 25 countries.
Developer of antibody-based drugs for cancer treatment. The company develops products using bispecific antibody engineering and advanced screening technologies that engage the power of the immune system to kill cancer cells. Its products include Zenocutuzomab, Petosemtamab, and MCLA-145 for lung, pancreatic and other cancers.
Developer of therapeutics for pain treatment after surgery. The company's lead product BR-003 is a highly elastic and biodegradable hydrogel designed to be attached to commercially available screws used in spinal surgery.
Xpand biotech has developed mini-bioreactors for cell culture as an alternative to the 2D cell culture system. Also, the company has used the system to study regenerative medicine, with a focus on bone tissue regeneration using calcium phosphate-based material, that has osteoconductive properties.
Developer of a non-invasive device for the early detection of delirium. The company offers an EEG-based device that consists of a single-use electrode patch and a hardware/software module that analyses brain activity.
Europa
Utrecht Holdings
EIC Fund
ROM Utrecht Region
Health Innovations
Medicxi
Utrecht Holdings Seed Fund
EIT Health
Invest-NL
Life Sciences Partners
Thuja Capital
Aglaia
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-23.
_1537501792425.png){kind=logo}
_1569839909751.png){kind=logo}
